Business Context and Reporting Period
Sunshine Biopharma Inc. (SBFM), a Colorado corporation with principal offices in Fort Lauderdale, Florida, filed this Form 8-K on September 24, 2025. The filing reports a change in the Company's independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity metrics within this document.
Material Changes
The primary material change reported is the dismissal of Bush & Associates CPA LLC as the Company's independent auditor, effective September 24, 2025. Concurrently, the Company retained M&K CPAS, PLLC as its new independent auditor. This decision was approved by the unanimous consent of the Board of Directors and the Audit Committee.
Guidance, Outlook, and Risks
The filing confirms that during the fiscal years ended December 31, 2023 and 2024, and the interim period through September 24, 2025, there were no disagreements with the former auditor regarding accounting principles, financial statement disclosures, or auditing scope. Furthermore, no "reportable events" occurred during this period. The audit reports for 2023 and 2024 were unqualified and did not contain adverse opinions, disclaimers, or modifications regarding uncertainty or scope. No consultations with the new auditor regarding accounting principles or audit opinions were conducted prior to their retention.
Investor Verification Checklist
- Verify the receipt of the letter from Bush & Associates CPA LLC confirming their agreement with the Company's disclosures, which is noted as pending and to be filed by amendment.
- Confirm the transition timeline and scope of work for the new auditor, M&K CPAS, PLLC.
- Review upcoming financial filings to ensure continuity in audit quality and reporting standards following the change.